Skip to content

A clinical study on the inhibition of etomidate induced tracheal intubation response during general anesthesia with low-dose ciprofol pretreatment

A clinical study on the inhibition of etomidate induced tracheal intubation response during general anesthesia with low-dose ciprofol pretreatment

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077996
Enrollment
Unknown
Registered
2023-11-27
Start date
2023-11-28
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesiology

Interventions

Ciprofol group:Anesthesia induced intravenously administered ciprofol and etomidate, and maintained intravenously administered ciprofol
NS group:Anesthesia induced intravenously administered normal saline and etomidate, and maintained intravenously administered ciprofol

Sponsors

First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-60, ASAI-III grade, who undergo elective intubation and general anesthesia, are scheduled to be sent to a recovery room for resuscitation and tracheal catheter removal after surgery.

Exclusion criteria

Exclusion criteria: 1.Severe hypertension (systolic blood pressure = 180mmHg, or diastolic blood pressure = 110mmHg); 2.Tachycardia (heart rate>100 beats/min); 3. Coronary heart disease; 4. Difficult airway; 5.Adrenal cortical dysfunction; 6. Patients with severe heart, liver, lung, or kidney diseases; 7. Severe anemia, shock, metabolic disorders, electrolyte disorders; 8. Severe infections (sepsis, sepsis, brain abscess); 9. Pregnant women; 10. Patients who are unable to communicate; 11. Patients with delayed gastric retention or gastric emptying; 12. Patients who abuse hormones or anesthetic analgesics; 13. Individuals who are allergic to the studied medication.

Design outcomes

Primary

MeasureTime frame
Positive rate of cardiovascular reaction during tracheal intubation;

Secondary

MeasureTime frame
vital signs;The total amount of vasoactive drugs used during anesthesia induction and maintenance periods;Total amount of anesthetic drugs;Anesthesia and surgical related time;

Countries

China

Contacts

Public ContactXuehai Guan

First Affiliated Hospital of Guangxi Medical University

guan_xh@aliyun.com+86 185 8769 7310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026